CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 6
- ScaleLevered free cash flow is $23.99M, above the global median of $16.24M
- PositionGross margin is 60.9%, higher than 95% of its Specialty Chemicals peers (median 23.4%)
- Interpretations7 currently firing — 7
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.48%
Annual Rate
INR 4.00Paid semi-annual
Payout Ratio
27.4%Sustainable
Next Ex-Dividend
Sep 3, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
87.74BINR916.49M · vs all stocks (USD)
Trailing P/E
37.45xvs Specialty Chemicals peers
Revenue (TTM)
9.82BINR102.59M · vs all stocks (USD)
Profit Margin
23.72%vs Specialty Chemicals peers
Beta
0.2520xvs all stocks
52-Week Change
-28.45%vs all stocks
Forward Annual Dividend Yield
0.48%vs all stocks
Market Capitalization
87.74BINR916.49M · vs all stocks (USD)
Enterprise Value
83.36BINR870.81M · vs all stocks (USD)
Trailing P/E
37.45xvs Specialty Chemicals peers
Forward P/E
25.40xvs Specialty Chemicals peers
PEG Ratio
-37.28xvs Specialty Chemicals peers
Price to Sales (TTM)
8.87xvs Specialty Chemicals peers
Price to Book (MRQ)
5.50xvs Specialty Chemicals peers
Enterprise to Revenue
8.49xvs Specialty Chemicals peers
Enterprise to EBITDA
23.71xvs Specialty Chemicals peers
Gross Margin
60.92%vs Specialty Chemicals peers
Profit Margin
23.72%vs Specialty Chemicals peers
Operating Margin
28.08%vs Specialty Chemicals peers
Return on Assets (TTM)
12.88%vs Specialty Chemicals peers
Return on Equity (TTM)
14.50%vs Specialty Chemicals peers
Revenue (TTM)
9.82BINR102.59M · vs all stocks (USD)
Revenue per Share (TTM)
92.42INRUpdated Aug 21, 2026Quarterly Revenue Growth
10.50%vs Specialty Chemicals peers
Gross Profit (TTM)
6.04BINR63.07M · vs all stocks (USD)
EBITDA (TTM)
4.12BINR43.09M · vs all stocks (USD)
Net Income (TTM)
2.33BINR24.33M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
4.70%vs Specialty Chemicals peers
Operating Cash Flow (TTM)
2.75BINR28.68M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
2.30BINR23.99M · vs all stocks (USD)
Forward Annual Dividend Rate
4.00INRUpdated Aug 21, 2026Forward Annual Dividend Yield
0.48%vs all stocks
Trailing Annual Dividend Rate
6.00INRUpdated Aug 21, 2026Trailing Annual Dividend Yield
0.73%vs all stocks
Payout Ratio
27.38%vs Specialty Chemicals peers
Revenue
9.57BINRFY2026 · Mar 31, 2026Cost of Goods Sold
3.57BINRFY2026 · Mar 31, 2026Gross Profit
5.99BINRFY2026 · Mar 31, 2026Operating Income
2.77BINR28.98M · vs all stocks (USD)
Pre-tax Income
3.10BINRFY2026 · Mar 31, 2026Income Tax Expense
800.15MINRFY2026 · Mar 31, 2026Net Income
2.30BINRFY2026 · Mar 31, 2026EBIT
3.10BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
3.88BINRFY2026 · Mar 31, 2026Other Operating Expenses
1.96BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
3.54MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
2.88BINRFY2026 · Mar 31, 2026Free Cash Flow
879.80MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
280.20MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
3.10BINRFY2026 · Mar 31, 2026Stock-based Compensation
23.32MINRFY2026 · Mar 31, 2026Other Non-cash Items
-45.72MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-7.30MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-182.25MINRFY2026 · Mar 31, 2026Capital Expenditures
-2.00BINRFY2026 · Mar 31, 2026Purchase of Investments
-7.63BINRFY2026 · Mar 31, 2026Sale of Investments
7.59BINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-2.04BINRFY2026 · Mar 31, 2026Common Dividends Paid
-637.65MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-632.63MINRFY2026 · Mar 31, 2026Shares Outstanding
106.28MSharesUpdated Aug 21, 2026Float Shares
52.26MSharesUpdated Aug 21, 2026% Held by Insiders
55.21%vs all stocks
% Held by Institutions
24.42%vs all stocks
Total Cash (MRQ)
3.75BINR39.21M · vs all stocks (USD)
Total Cash per Share (MRQ)
35.31INRUpdated Aug 21, 2026Total Debt (MRQ)
21.39MINR223.44K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0014xvs Specialty Chemicals peers
Current Ratio (MRQ)
5.01xvs Specialty Chemicals peers
Book Value per Share (MRQ)
148.94INRUpdated Aug 21, 2026Total Assets
17.83BINR186.24M · vs all stocks (USD)
Total Current Assets
8.28BINRFY2026 · Mar 31, 2026Total Liabilities
1.99BINRFY2026 · Mar 31, 2026Total Non-current Assets
9.55BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
338.42MINRFY2026 · Mar 31, 2026Total Current Liabilities
1.65BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
280.20MINRFY2026 · Mar 31, 2026Other Short-term Investments
3.54BINRFY2026 · Mar 31, 2026Accounts Receivable
2.06BINRFY2026 · Mar 31, 2026Inventory
1.54BINRFY2026 · Mar 31, 2026Accounts Payable
1.16BINRFY2026 · Mar 31, 2026Short-term Debt
1.72MINRFY2026 · Mar 31, 2026Other Current Liabilities
48.35MINRFY2026 · Mar 31, 2026Long-term Debt
19.67MINRFY2026 · Mar 31, 2026Common Stock (Book)
106.28MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
15.84BINR165.44M · vs all stocks (USD)
52-Week Low
652.00INRUpdated Aug 21, 202652-Week High
1.22KINRUpdated Aug 21, 202652-Week Change
-28.45%vs all stocks
Beta
0.2520xvs all stocks
50-Day MA
773.14INRUpdated Aug 21, 2026200-Day MA
798.91INRUpdated Aug 21, 2026Avg 10-Day Volume
513.41KSharesUpdated Aug 21, 2026Avg 30-Day Volume
452.63KSharesUpdated Aug 21, 2026Diluted EPS (TTM)
21.88INRUpdated Aug 21, 20267 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 60.9%, higher than 95% of its Specialty Chemicals peers (median 23.4%)Significant
Gross margin: 0.61Industry median: 0.23Industry P95: 0.47Peers compared: 268
Operating margin is 28.1%, higher than 95% of its Specialty Chemicals peers (median 6.2%)Significant
Operating margin: 0.28Industry median: 0.06Industry P95: 0.21Peers compared: 268
Profit margin is 23.7%, higher than 95% of its Specialty Chemicals peers (median 3.7%)Significant
Profit margin: 0.24Industry median: 0.04Industry P95: 0.17Peers compared: 268
Return on assets is 12.9%, higher than 95% of its Specialty Chemicals peers (median 2.8%)Significant
Return on assets: 0.13Industry median: 0.03Industry P95: 0.11Peers compared: 268
Debt-to-equity is 0×, lower than 95% of its Specialty Chemicals peers (median 0.32×)Notable
Debt-to-equity: 0.00Industry median: 0.32Industry P5: 0.01Peers compared: 268
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 0.54
Supply Chain
Downstream position: depends on 10 industries, supplies 6Notable
Outgoing: 6.00Incoming: 10.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Levered free cash flow is $23.99M, above the global median of $16.24MNotable
Levered free cash flow (USD): 23,989,761.3Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Anhui Sierte Fertilizer Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Zhejiang Grandwall Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Indo Count Industries Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Aksa Akrilik Kimya Sanayii A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Hubei Tech Semiconductors Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Oceanking Development Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhonghong Pulin Medical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Keystone Microtech Corporation
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
CGN Nuclear Technology Development Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shenzhen Uniconn Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Shift Up Corp.
7 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity Configuration
Shanghai MicroPort Endovascular MedTech Co., Ltd.
7 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity Configuration
Shenzhen New Industries Biomedical Engineering Co., Ltd.
7 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity Configuration
Supply Chain
Petrochemicals Supply Chain
Follow hydrocarbons through cracking, separation, polymers, conversion, use, and recovery. A cracker produces a coupled slate, so feedstock, product demand, contracts, plant configuration, and waste routes constrain one another.
Plastics Supply Chain
Follow feedstock through monomer and polymer production, compounding, conversion, packaging, use, collection, recycling, combustion, and disposal. Resin tonnes and recycling rates are bounded measurements, not proof that the original function returned.
Natural Rubber Supply Chain
Follow natural rubber from tree and tapping through coagulation, grading, compounding, vulcanization, service, and recovery. The chain preserves some properties while closing others, and money arrives on a faster clock than a new stand of trees.